Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination

被引：1
作者：
Crea, Filippo [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷 / 39期
关键词：
HEART;
D O I：
10.1093/eurheartj/ehab712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
With thanks to Amelia Meier-Batschelet, Johanna Huggler, and Martin Meyer for help with compilation of this article.
引用
收藏
页码：3995 / 3999
页数：5
相关论文
共 24 条
[1]  
Aboyans V, 2021, EUR HEART J, V42, P4013, DOI DOI 10.1093/eurheartj/ehab390
[2]  
Anker SD, 2020, EUR HEART J, V41, P2109, DOI DOI 10.1093/eurheartj/ehaa461
[3]  
Cao Cao D D, 2021, EUR HEART J, V42 42, P339, DOI DOI 10.1093/eurheartj/ehaa824
[4]  
Chieffo A, 2020, EUR HEART J, V41, P1839, DOI DOI 10.1093/eurheartj/ehaa381
[5]  
Connors JM, 2021, EUR HEART J, V42, P4073, DOI DOI 10.1093/eurheartj/ehab585
[6]   Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction [J].
Crea, Filippo .
EUROPEAN HEART JOURNAL, 2021, 42 (31) :2973-2974
[7]  
Fernando H, 2021, EUR HEART J, V42, P4025, DOI DOI 10.1093/eurheartj/ehab557
[8]  
Galli M, 2021, EUR HEART J, V42, P4037, DOI DOI 10.1093/eurheartj/ehab595
[9]  
Giral P, 2021, EUR HEART J, V42, P4092, DOI DOI 10.1093/eurheartj/ehab256
[10]  
Hinterdobler J, 2021, EUR HEART J, V42, P4077, DOI DOI 10.1093/eurheartj/ehab371
123